Lipocine Inc. (LPCN): Cash & Equivalents
$5.21M
As of 2025-12-31
$4.98M
As of 2026-06-30
+18.2%
3-year compound annual growth
-23.0%
5-year compound annual growth
-12.6%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $5.21M | -16.1% | 2026-03-10, Balance as of period end |
| 2024-12-31 | $6.21M | +30.1% | 2026-03-10, Balance as of period end |
| 2023-12-31 | $4.77M | +51.6% | 2025-03-13, Balance as of period end |
| 2022-12-31 | $3.15M | +6.7% | 2024-03-07, Balance as of period end |
| 2021-12-31 | $2.95M | -84.6% | 2023-03-10, Balance as of period end |
| 2020-12-31 | $19.22M | +97.5% | 2022-03-09, Balance as of period end |
| 2019-12-31 | $9.73M | +20.4% | 2021-03-11, Balance as of period end |
| 2018-12-31 | $8.08M | +151.6% | 2020-03-13, Balance as of period end |
| 2017-12-31 | $3.21M | -42.3% | 2019-03-06, Balance as of period end |
| 2016-12-31 | $5.56M | -72.2% | 2018-03-12, Balance as of period end |
| 2015-12-31 | $20.01M | -27.7% | 2018-03-12, Balance as of period end |
| 2014-12-31 | $27.67M | -38.9% | 2017-03-06, Balance as of period end |
| 2013-12-31 | $45.26M | +741.8% | 2015-03-11, Balance as of period end |
| 2012-12-31 | $5.38M | n/m | 2014-03-31, Balance as of period end |
| 2011-12-31 | $22.9K | n/a | 2013-02-26, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Lipocine Inc. (LPCN) | 2025-12-31 | $5.21M | -16.1% |
| Dianthus Therapeutics, Inc. (DNTH) | 2025-12-31 | $51.09M | +124.1% |
| Bio Essence Corp (BIOE) | 2024-12-31 | $1.4K | n/m |
| Korsana Biosciences, Inc. (KRSA) | 2025-12-31 | $3.24M | +0.2% |
| Rani Therapeutics Holdings, Inc. (RANI) | 2025-12-31 | $18.62M | +394.9% |
| GeoVax Labs, Inc. (GOVX) | 2025-12-31 | $3.09M | -44.0% |
| NRX Pharmaceuticals, Inc. (NRXP) | 2025-12-31 | $7.80M | +440.3% |
| Avenue Therapeutics, Inc. (ATXI) | 2025-12-31 | $2.85M | +10.1% |
| Cartesian Therapeutics, Inc. (RNAC) | 2025-12-31 | $125.14M | -41.1% |
Compare LPCN, DNTH, BIOE, KRSA side by side · Screen every company in Pharmaceutical Preparations ↗